Baxter International, the leading supplier of intravenous (IV) solutions to hospitals in the United States, said on Oct. 28 that it received approval from the Food and Drug Administration (FDA) to extend the expiry dates of its products.
Baxter temporarily shut down its North Cove manufacturing plant in North Carolina on Sept. 29 due to the impact of Hurricane Helene, which led to a shortage in the supply of IV fluids.
The FDA has allowed a 24-month expiry period for over 50 IV and irrigation products, doubling the standard one-year shelf life, Baxter said in a statement.
The changes apply to products manufactured before September 2024. The company said that it has communicated the expiry date extension details to its customers….